Base period - R & D support services

Ended Definitive Contract Awarded Last action

Contract number
N6264517C4023
Awardee
Awarding agency
Obligated
$2,730,994

Award facts

Opportunity
Contract value 72% obligated
$3,774,462.04 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Cost Plus Fixed Fee
Place of performance
Poquonock Bridge, CT 06340, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00017 -$11,398
Funding Only Action P00016 $2,100
Funding Only Action P00015 -$136,874
Funding Only Action P00014 -$106,074
Other Administrative Action P00013 $2,880
Funding Only Action P00012 $315,457
Other Administrative Action P00011 $0
Funding Only Action P00010 -$181,146
Funding Only Action P00009 $224,998
Exercise an Option P00008 $92,155
Funding Only Action P00007 $101,870
Exercise an Option P00006 $213,065
Exercise an Option P00005 $239,972
Funding Only Action P00004 $135,331
Funding Only Action P00003 $421,841
Supplemental Agreement for work within scope P00002 $0
Funding Only Action P00001 $1,193,153
Original award $223,663
Show all 18

About this award

Written by GovTribe AI ·

This federal contract award was made by the Bureau of Medicine and Surgery, a Defense agency, to the prime contractor Leidos, Inc. for $3,774,462.04 in R&D support services. The contract is a Cost Plus Fixed Fee Definitive Contract with a period of performance through May 2018. It is not designated as a set-aside contract.

As a global leader in information technology and engineering solutions, Leidos has supported numerous federal agencies through both prime and subcontract awards. For this contract, Leidos utilized subcontractors MAK Technologies, Inc. and Creare LLC to provide procured goods and services in support of the statement of work. MAK Technologies is a foreign-owned firm specializing in military simulation technologies, while Creare LLC is an engineering research and development company with expertise across defense, aerospace, and energy domains. This award appears to be part of the Bureau of Medicine and Surgery's broader medical research programs, which may include focus areas such as traumatic brain injury, psychological health, cancer, and rare diseases.

Quick answers

Who was awarded contract N6264517C4023?

N6264517C4023 was awarded to Leidos, Inc. by Bureau of Medicine and Surgery (Department of the Navy) on August 31, 2017.

How much is contract N6264517C4023 worth?

The government has obligated $2,730,994 on N6264517C4023. Its current value, with exercised options, is $3,774,462.

Was contract N6264517C4023 competed?

The extent of competition for N6264517C4023 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login